Stopped
Pre Operative Trastuzumab in Operable Breast Cancer
Trial terminated
Also in this update: Primary completion date changed from estimate of Apr 2025 to Sep 11, 2026
Dr Rajendra A. BadwePhase 3 NCT01785420 Registry history of NCT01785420 on ClinicalTrials.gov (opens the registry)